Endocrine therapy – current benefits and limitations Robert I. NicholsonStephen R. Johnston OriginalPaper 15 October 2005 Pages: 3 - 10
Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance Mitch DowsettRobert I. NicholsonRichard J. Pietras OriginalPaper 15 October 2005 Pages: 11 - 18
Life following aromatase inhibitors – where now for endocrine sequencing? Stephen R. JohnstonLesley-Ann MartinMitch Dowsett OriginalPaper 15 October 2005 Pages: 19 - 25